What Is Metastatic Endometrial Cancer? Metastatic endometrial cancer is when cancer that starts in the lining of the uterus (endometrium) spreads to other parts of the body. Your doctor may call it ...

Characterization of copy number variations (CNV) patterns and pseudotime trajectories in high-grade serous ovarian cancer (HGSOC). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...

The National Institute for Health and Care Excellence (NICE) has recommended a combination treatment for advanced endometrial cancer, calling it a “major step forward.” This is the first time ...

Gynecological clear cell cancers (CCCs), very aggressive forms of ovarian and endometrial malignancies, respond poorly to chemotherapy. The low response rates underscore a significant clinical need to ...

Please provide your email address to receive an email when new articles are posted on . A novel two-drug combination exhibited antitumor activity among certain women with advanced endometrial cancer, ...

Results from the SIENDO trial examining the effects of Xpovio as a frontline maintenance therapy in patients with advanced or recurrent endometrial cancer highlighted a significant survival benefit. A ...

Breakthrough Therapy Designation granted to Rina-S for the treatment of adult patients with recurrent or progressive endometrial cancer (EC) who have disease progression on or following prior ...

High metabolic activity of visceral fat may be associated with more aggressive endometrial cancer, new research presented today at the 38th Annual Congress of the European Association of Nuclear ...

Endometrial cancer occurs when the cells in the inner lining of the uterus (womb) grow out of control. It's the most common type of uterine cancer and usually affects women after menopause, with ...

The endometrial cancer market space will experience significant growth during the forecast period of 2025--2034. The future is brighter for patients with endometrial cancer. Targeted agents and ...